Search
Search Results
##search.searchResults.foundPlural##
-
UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC)
3890Suppl. Files: 1104PDF: 1061Html: 170 -
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
4783PDF: 1776HTML: 2704Untitled: 213 -
LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM? Letermovir and Cytomegalovirus Prophylaxis in HSCT
1287PDF: 1008HTML: 120 -
CYTOMEGALOVIRUS REACTIVATION IN ADULT RECIPIENTS OF AUTOLOGOUS STEM CELL TRANSPLANTATION: A SINGLE CENTER EXPERIENCE
1542PDF: 877HTML: 976figures: 177table 1: 180table2: 179table3: 180 -
Refractory Immune Thrombocytopenic Purpura and Cytomegalovirus Infection: A Call for a Change in the Current Guidelines
4242PDF: 1170HTML: 2151Figure 1: 162 -
Toxic epidermal necrolysis associated with severe cytomegalovirus infection in a patient on regular hemodialysis.
1743PDF: 528HTML: 16966Figure 4: 166Figure 3: 138Figure 2: 144Figure 1: 175 -
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS. Anti-CMV immunoglobulins for CMV treatment
1921PDF: 1159HTML: 265 -
Acute Cytomegalovirus infection as a cause of venous thromboembolism
1562PDF: 843HTML: 1031Picture 1: 165 -
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
3859PDF: 1469HTML: 8510 -
Focusing On A Unique Innate Memory Cell Population Of Natural Killer Cells In The Fight Against COVID-19: Harnessing The Ubiquity Of Cytomegalovirus Exposure Memory Cell Population Of Natural Killer Cells in COVID-19 and Cytomegalovirus Exposure
1149PDF: 909HTML: 286 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1379PDF: 814HTML: 3117 -
COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis
1370PDF: 1301HTML: 94 -
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
3746PDF: 1472HTML: 482Figures . Eliassian: 220 -
Guest Editor: G. Castaman GENE THERAPY FOR HEMOPHILIA: FACTS AND QUANDARIES IN THE 21ST CENTURY GENE THERAPY FOR HEMOPHILIA
2038PDF: 1857HTML: 342 -
Kikuchi-Fujimoto disease and hemophagocytic lymphohistiocytosis: a rare combination of two rare diseases
759PDF: 569Suppl. Files: 123HTML: 87 -
Stroke in a patient with tuberculous meningitis and HIV infection
1574PDF: 798HTML: 1724figure 1: 157 -
Status Epilepticus Due to Severe HHV-6 Encephalitis in an Allogeneic Stem Cell Transplant Recipient
1157PDF: 822HTML: 2179Figue 1: 171 -
NURSING MANAGEMENT OF HAEMORRHAGIC CYSTITIS IN PATIENTS UNDERGOING HAEMATOPOIETIC STEM CELL TRANSPLANTATION: A MULTICENTRE ITALIAN SURVEY Nursing management of haemorrhagic cystitis
1846PDF: 1045HTML: 242 -
Epstein-Barr Virus (EBV)-associated Haemophagocytic Syndrome
1830PDF: 828HTML: 1578 -
NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL
2480PDF: 835HTML: 8815Efremov 1: 224Efremov 2: 184 -
Tacrolimus Associated Posterior Reversible Encephalopathy Syndrome – A Case Series and Review
3538PDF: 1476HTML: 4384CoverLetter: 183Figure1: 194 -
-
HEMATOLOGICAL ABNORMALITIES BEYOND LYMPHOCYTOSIS DURING INFECTIOUS MONONUCLEOSIS: EPSTEIN-BARR VIRUS-INDUCED THROMBOCYTOPENIA THROMBOCYTOPENIA DURING INFECTIOUS MONONUCLEOSIS
1983HTML: 536PDF: 1196 -
ZYGOMYCOSIS IN IMMUNOCOMPROMISED NON-HAEMATOLOGICAL PATIENTS
2802PDF: 944HTML: 7330 -
A Rare Case of Rosai-Dorfman Disease in an Adult Male Associated with Auto-immune Hemolytic Anemia.
1378PDF: 914HTML: 1648Figure 1: 178 -
IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS
3041PDF: 871HTML: 7162Kost Fig1: 178Kost Fig 2: 176Kost Fig3: 173Kost Fig 4: 186Kost Fig5: 183Kost fig 6: 171 -
Lymphomatoid Granulomatosis of Central Nervous System and Lung Driven by Epstein Barr Virus Proliferation: Successful Treatment with Rituximab
1599PDF: 879HTML: 3154Figure 5: 153Figure 4: 157Figure 3: 191Figure 1: 169Figure 2: 165







